These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38901087)

  • 1. HPV-driven oropharyngeal cancer burden in Paris and its region (ILE DE FRANCE) from 1981 TO 2021.
    Mirghani H; Tendron A; Auperin A; Casiraghi O; Classe M; Badoual C; Legoupil C; Puech J; Veyer D; Dalstein V; Pere H; Gorphe P
    Cancer Epidemiol; 2024 Aug; 91():102603. PubMed ID: 38901087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and characteristics of HPV-driven oropharyngeal cancer in France.
    Mirghani H; Bellera C; Delaye J; Dolivet G; Fakhry N; Bozec A; Garrel R; Malard O; Jegoux F; Maingon P; Sarini J; Noel G; Duflo S; Temam S; Lefebvre JL; Costes-Martineau V
    Cancer Epidemiol; 2019 Aug; 61():89-94. PubMed ID: 31158796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rising incidence of HPV positive oropharyngeal cancer in Taiwan between 1999 and 2014 where betel nut chewing is common.
    Wang CP; Chen TC; Hsu WL; Hsiao JR; Chen PR; Chen MK; Hua CH; Tsai MH; Ko JY; Lou PJ; Chiang CJ; Wu CT; Chang YL
    BMC Cancer; 2022 Mar; 22(1):296. PubMed ID: 35313837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-independent increasing prevalence of Human Papillomavirus-driven oropharyngeal carcinomas in North-East Italy.
    Del Mistro A; Frayle H; Menegaldo A; Favaretto N; Gori S; Nicolai P; Spinato G; Romeo S; Tirelli G; da Mosto MC; Polesel J; Boscolo Rizzo P
    Sci Rep; 2020 Jun; 10(1):9320. PubMed ID: 32518378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
    Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
    Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV DNA genotyping, HPV E6*I mRNA detection, and p16
    Simoens C; Gorbaslieva I; Gheit T; Holzinger D; Lucas E; Ridder R; Rehm S; Vermeulen P; Lammens M; Vanderveken OM; Kumar RV; Gangane N; Caniglia A; Maffini F; Rubio MBL; Anantharaman D; Chiocca S; Brennan P; Pillai MR; Sankaranarayanan R; Bogers J; Pawlita M; Tommasino M; Arbyn M;
    Cancer Epidemiol; 2021 Jun; 72():101925. PubMed ID: 33839457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
    Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does smoking alter the mutation profile of human papillomavirus-driven head and neck cancers?
    Mirghani H; Lacroix L; Rossoni C; Sun R; Aupérin A; Casiraghi O; Villepelet A; Lacave R; Faucher G; Marty V; Ferté C; Soria JC; Even C
    Eur J Cancer; 2018 May; 94():61-69. PubMed ID: 29533868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population.
    Evans M; Newcombe R; Fiander A; Powell J; Rolles M; Thavaraj S; Robinson M; Powell N
    BMC Cancer; 2013 May; 13():220. PubMed ID: 23634887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
    Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
    Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011 to 2014.
    Carlander AF; Grønhøj Larsen C; Jensen DH; Garnæs E; Kiss K; Andersen L; Olsen CH; Franzmann M; Høgdall E; Kjær SK; Norrild B; Specht L; Andersen E; van Overeem Hansen T; Nielsen FC; von Buchwald C
    Eur J Cancer; 2017 Jan; 70():75-82. PubMed ID: 27888679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging risk of oropharyngeal and oral cavity cancer in HPV-related subsites in young people in Brazil.
    Menezes FDS; Latorre MDRDO; Conceição GMS; Curado MP; Antunes JLF; Toporcov TN
    PLoS One; 2020; 15(5):e0232871. PubMed ID: 32407339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
    JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe.
    Mena M; Frias-Gomez J; Taberna M; Quirós B; Marquez S; Clavero O; Baena A; Lloveras B; Alejo M; León X; García J; Mesía R; Bermejo O; Bonfill T; Aguila A; Guix M; Hijano R; Pavón MA; Torres M; Tous S; Clèries R; Alemany L
    Sci Rep; 2020 Aug; 10(1):13219. PubMed ID: 32764593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
    Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
    Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary High-Risk Human Papillomavirus (HPV) DNA as a Biomarker for HPV-Driven Head and Neck Cancers.
    Ekanayake Weeramange C; Liu Z; Hartel G; Li Y; Vasani S; Langton-Lockton J; Kenny L; Morris L; Frazer I; Tang KD; Punyadeera C
    J Mol Diagn; 2021 Oct; 23(10):1334-1342. PubMed ID: 34325059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of human papillomavirus in cancer of the oropharynx by gender.
    Combes JD; Chen AA; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2954-8. PubMed ID: 25205515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Human Papillomavirus Enigma: A Narrative Review of Global Variations in Oropharyngeal Cancer Epidemiology and Prognosis.
    Singhavi HR; Chaturvedi P; Nair D
    Indian J Public Health; 2024 Apr; 68(2):268-275. PubMed ID: 38953816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers.
    Chaturvedi AK; Anderson WF; Lortet-Tieulent J; Curado MP; Ferlay J; Franceschi S; Rosenberg PS; Bray F; Gillison ML
    J Clin Oncol; 2013 Dec; 31(36):4550-9. PubMed ID: 24248688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary.
    Tanaka H; Suzuki M; Takemoto N; Fukusumi T; Eguchi H; Takai E; Kanai H; Tatsumi M; Horie M; Takenaka Y; Yachida S; Inohara H
    Int J Cancer; 2022 Jan; 150(1):174-186. PubMed ID: 34486724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.